B. Agerberth et al., FALL-39, A PUTATIVE HUMAN PEPTIDE ANTIBIOTIC, IS CYSTEINE-FREE AND EXPRESSED IN BONE-MARROW AND TESTIS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(1), 1995, pp. 195-199
PR-39, a proline/arginine-rich peptide antibiotic, has been purified f
rom pig intestine and later shown to originate in the bone marrow. Int
ending to isolate a clone for a human counterpart to PR-39, we synthes
ized a PCR probe derived from the PR 39 gene. However, when this probe
was used to screen a human bone marrow cDNA library, eight clones wer
e obtained with information for another putative human peptide antibio
tic, designated FALL-39 after the first four residues. FALL-39 is a 39
-residue peptide lacking cysteine and tryptophan. All human peptide an
tibiotics previously isolated (or predicted) belong to the defensin fa
mily and contain three disulfide bridges. The clone for prepro-FALL-39
encodes a cathelin-like precursor protein with 170 amino acid residue
s, We have postulated a dibasic processing site for the mature FALL-39
and chemically synthesized the putative peptide. In basal medium E, s
ynthetic FALL-39 was highly active against Escherichia coil and Bacill
us megaterium. Residues 13-34 in FALL-39 can be predicted to form a pe
rfect amphiphatic helix, and CD spectra showed that medium E induced 3
0% helix formation in FALL-39. RNA blot analyses disclosed that the ge
ne for FALL-39 is expressed mainly in human bone marrow and testis.